Report Detail
Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Professional Survey Report 2019
- RnM2840940 |
- 30 January, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
The global Squamous Non-Small Cell Lung Cancer Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Squamous Non-Small Cell Lung Cancer Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Squamous Non-Small Cell Lung Cancer Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Squamous Non-Small Cell Lung Cancer Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Squamous Non-Small Cell Lung Cancer Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Ascenta Therapeutics, Inc.
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Bayer AG
BIND Therapeutics, Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
Genentech, Inc.
Incyte Corporation
Johnson & Johnson
MacroGenics, Inc.
Novartis AG
Oncogenex Pharmaceuticals, Inc.
PsiOxus Therapeutics Limited
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
BMS-906024
Buparlisib Hydrochloride
FP-1039
Ipilimumab
JNJ-42756493
Lenvatinib
Others
Segment by Application
Research Center
Hospital
Clinic
Table of Contents
Executive Summary
1 Industry Overview of Squamous Non-Small Cell Lung Cancer Therapeutics
- 1.1 Definition of Squamous Non-Small Cell Lung Cancer Therapeutics
- 1.2 Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Type
- 1.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 BMS-906024
- 1.2.3 Buparlisib Hydrochloride
- 1.2.4 FP-1039
- 1.2.5 Ipilimumab
- 1.2.6 JNJ-42756493
- 1.2.7 Lenvatinib
- 1.2.8 Others
- 1.3 Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Applications
- 1.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Research Center
- 1.3.3 Hospital
- 1.3.4 Clinic
- 1.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Overall Market
- 1.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (2014-2025)
- 1.4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Production (2014-2025)
- 1.4.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
- 1.4.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
- 1.4.5 China Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
- 1.4.6 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
- 1.4.8 India Squamous Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Squamous Non-Small Cell Lung Cancer Therapeutics
- 2.3 Manufacturing Process Analysis of Squamous Non-Small Cell Lung Cancer Therapeutics
- 2.4 Industry Chain Structure of Squamous Non-Small Cell Lung Cancer Therapeutics
3 Development and Manufacturing Plants Analysis of Squamous Non-Small Cell Lung Cancer Therapeutics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Squamous Non-Small Cell Lung Cancer Therapeutics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Squamous Non-Small Cell Lung Cancer Therapeutics Production and Capacity Analysis
- 4.2 Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Analysis
- 4.3 Squamous Non-Small Cell Lung Cancer Therapeutics Price Analysis
- 4.4 Market Concentration Degree
5 Squamous Non-Small Cell Lung Cancer Therapeutics Regional Market Analysis
- 5.1 Squamous Non-Small Cell Lung Cancer Therapeutics Production by Regions
- 5.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Production by Regions
- 5.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Regions
- 5.2 Squamous Non-Small Cell Lung Cancer Therapeutics Consumption by Regions
- 5.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis
- 5.3.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Production
- 5.3.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Squamous Non-Small Cell Lung Cancer Therapeutics Import and Export
- 5.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis
- 5.4.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Production
- 5.4.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Import and Export
- 5.5 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis
- 5.5.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Production
- 5.5.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Import and Export
- 5.6 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis
- 5.6.1 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Production
- 5.6.2 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Import and Export
- 5.7 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis
- 5.7.1 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Production
- 5.7.2 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Import and Export
- 5.8 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis
- 5.8.1 India Squamous Non-Small Cell Lung Cancer Therapeutics Production
- 5.8.2 India Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Squamous Non-Small Cell Lung Cancer Therapeutics Import and Export
6 Squamous Non-Small Cell Lung Cancer Therapeutics Segment Market Analysis (by Type)
- 6.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Production by Type
- 6.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Type
- 6.3 Squamous Non-Small Cell Lung Cancer Therapeutics Price by Type
7 Squamous Non-Small Cell Lung Cancer Therapeutics Segment Market Analysis (by Application)
- 7.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Consumption by Application
- 7.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Share by Application (2014-2019)
8 Squamous Non-Small Cell Lung Cancer Therapeutics Major Manufacturers Analysis
- 8.1 Ascenta Therapeutics, Inc.
- 8.1.1 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.1.2 Ascenta Therapeutics, Inc. Product Introduction, Application and Specification
- 8.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 AstraZeneca Plc
- 8.2.1 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.2.2 AstraZeneca Plc Product Introduction, Application and Specification
- 8.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 AVEO Pharmaceuticals, Inc.
- 8.3.1 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.3.2 AVEO Pharmaceuticals, Inc. Product Introduction, Application and Specification
- 8.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Bayer AG
- 8.4.1 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.4.2 Bayer AG Product Introduction, Application and Specification
- 8.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 BIND Therapeutics, Inc.
- 8.5.1 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.5.2 BIND Therapeutics, Inc. Product Introduction, Application and Specification
- 8.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Boehringer Ingelheim GmbH
- 8.6.1 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.6.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
- 8.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Bristol-Myers Squibb Company
- 8.7.1 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.7.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
- 8.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Eli Lilly and Company
- 8.8.1 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.8.2 Eli Lilly and Company Product Introduction, Application and Specification
- 8.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 F. Hoffmann-La Roche Ltd.
- 8.9.1 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.9.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
- 8.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Five Prime Therapeutics, Inc.
- 8.10.1 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production Sites and Area Served
- 8.10.2 Five Prime Therapeutics, Inc. Product Introduction, Application and Specification
- 8.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Genentech, Inc.
- 8.12 Incyte Corporation
- 8.13 Johnson & Johnson
- 8.14 MacroGenics, Inc.
- 8.15 Novartis AG
- 8.16 Oncogenex Pharmaceuticals, Inc.
- 8.17 PsiOxus Therapeutics Limited
9 Development Trend of Analysis of Squamous Non-Small Cell Lung Cancer Therapeutics Market
- 9.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Trend Analysis
- 9.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Squamous Non-Small Cell Lung Cancer Therapeutics Regional Market Trend
- 9.2.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Forecast 2019-2025
- 9.2.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Forecast 2019-2025
- 9.2.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Forecast 2019-2025
- 9.2.4 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Forecast 2019-2025
- 9.2.5 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Forecast 2019-2025
- 9.2.6 India Squamous Non-Small Cell Lung Cancer Therapeutics Forecast 2019-2025
- 9.3 Squamous Non-Small Cell Lung Cancer Therapeutics Market Trend (Product Type)
- 9.4 Squamous Non-Small Cell Lung Cancer Therapeutics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Squamous Non-Small Cell Lung Cancer Therapeutics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Squamous Non-Small Cell Lung Cancer Therapeutics . Industry analysis & Market Report on Squamous Non-Small Cell Lung Cancer Therapeutics is a syndicated market report, published as Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Squamous Non-Small Cell Lung Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
